Invitrogen, Zyomyx, Molecular Devices, University of North Carolina, Bruker AXS, US Department of Energy, National Science Foundation | GenomeWeb

Invitrogen Licenses Zyomyx Patents; Zyomyx to Help Develop New Protein Chip Applications

Invitrogen has licensed several protein-chip patents from Zyomyx and has signed an R&D deal with the company to develop new products, Invitrogen said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.